Health
Mak Grants Professors David Serwadda, Phillipa Musoke a Lifetime Professor Emeritus Appointment
Published
3 years agoon

Professor David Serwadda has been offered a lifetime professor emeritus position at Makerere University. This decision was reached at the 489th meeting of Makerere University Council, the supreme governing body of the university, on recommendation and nomination of the chief academic organ of the University, the Senate acknowledging his exceptional contributions to academia.
The prestigious title of Emeritus Professor, is bestowed upon retired professors in line with the university’s policies, aims to retain exemplary scholars who have reached the mandatory retirement age. This is in accordance with the University’s Policy and Procedures for The Award of The Title “Emeritus Professor”; The purpose is to retain an academician who has attained his or her mandatory retirement age under the existing Employment Policy of the University.
Pursuant to university policy, an Emeritus Professor is expected to embody a set of key responsibilities, such as mentoring, continuous knowledge generation in his or her field of specialization, and promoting research and publications in peer-reviewed journals.

Professor Serwadda, 67, is an icon of academic excellence, prolific researcher and an expert in infectious disease-focused public health deeply interested in HIV clinical drug trials, HIV epidemiology, infectious disease surveillance, and HIV intervention program assessment. His great contributions have had a significant impact on the academic landscape over the course of a distinguished professional history that extend over 35 years having been appointed in Makerere University in 1993 and gone through the ranks to full Professor. This has been demonstrated in his research endeavors at Makerere University, leadership roles, and comprehensive teaching across undergraduate, master’s, and PhD levels.
In 1982, Professor Serwadda received his medical degree from Makerere University after which he went to Newcastle Upton Tyne Medical School in England for a Master of Science in Medicine in 1987. In 1990, he completed his Master of Medicine in Internal Medicine Makerere University in 1990 and subsequently obtained a Master of Public Health (Epidemiology) from the John Hopkins School of Hygiene in the United States in 1991. In recognition of his outstanding leadership in the HIV/AIDS response and his noteworthy scientific accomplishments, John Hopkins University awarded him an honorary doctorate in 2011.
In his illustrious university service career, that started off in the Department of Disease Control and Environmental Health at Makerere University School of Public Health (MakSPH), then Institute of Public Health (IPH). He was director and eventually Dean of the School of Public health for 8 years. Professor Serwadda is commended for his meritorious service to Makerere University he has excelled in teaching, mentorship of students and junior staff made significant contribution to both national and international research. Notable for his resourcefulness, extensive networks, and scholarly integrity, Prof. Serwadda’s vast contributions significantly elevated infectious disease research, boasting an impressive repertoire of approximately 400 publications.
He was instrumental in the founding of the Rakai Health Sciences Program, Makerere Walter Reed Project, and the Infectious Disease Institute (IDI) enhancing prominence both domestically and globally by means of innovative research endeavors.
Moreover, Prof. Serwadda’s remarkable memberships in eminent professional associations, broad committee participation, and recent appointment as Senior Editor of the acclaimed eLife Journal highlight his worldwide influence and dedication to the promotion of public health.
He is a reviewer of research proposals for; the National Institute of Health, Non-communicable illness in low-middle income countries 2016-; and Wellcome trust, population and public health 2008- and has attracted the University numerous research funds. Currently, he is the chair of the fundraising committee for MakSPH infrastructure, where he initiated the conversation with Johns Hopkins University and worked with the dean to negotiate a partnership that led to in the 1.1 million USD construction grant from Johns Hopkins University for American Schools and Hospitals Abroad (ASHA).
Professor Serwadda has demonstrated outstanding leadership in community service while serving in important roles at Makerere University, including Dean of the School of Public Health (2007–2009) and Director of the Institute of Public Health (2002–2007). Prior, he headed the Department of Environmental Health and Disease Control from 1999 to 2002 and served as the Executive Director of the Rakai Health Sciences Program from 1998 to 2017. He championed the creation of the MakSPH Grants Committee and Office, which he served as its chair until 2021. He currently serves on the Grants Management Committee of the Makerere University Research and Innovations Fund (MakRIF).
Several awards and honors have been bestowed upon Professor Serwadda. These include the following: The Visionary Guidance award by Uganda Health Marketing Group (2016); the Outstanding dedication to the HIV and AID response through services to TASO award in 2015; the Makerere University College of Health Sciences, School of Public Health founder; and the visionary and exceptional leadership in nurturing the HIV fellowship PROGRAM – 2014. Award of appreciation given in honor of the exceptional volume of scientific publications in 2013 Distinguished Service Award, British Council, 2008; Pioneer in Behavior-Based HIV Prevention, Harvard University, December 2006; Honorary Doctorate, John Hopkins University, May 2011; Johns Hopkins Bloomberg School of Public Health Alumni Knowledge of the World Award, October 2010.

The Vice Chancellor Professor Barnabas Nawangwe described the duo as long-serving and dedicated academics, who have diligently served Makerere University and Uganda at the College of Health Sciences until retirement.
“By accepting the appointment of Professor Emeritus, both Prof. Philippa Musoke and Prof. David Serwadda have expressed their readiness to allow Makerere University to continue tapping into their expertise and wealth of experience to mentor the next generation of academics and researchers, and to continuously generate knowledge in their fields of specialization, and promote research, publications and innovation. I thank them for their selfless service and congratulate them on this achievement,” said Professor Nawangwe.
Professor Philippa Musoke (MBChB, FAAP, PhD) is a US board-certified Paediatric Infectious Diseases specialist in the Department of Paediatrics and Child Health, School of Medicine College of Health Sciences, Makerere University and is currently based at the Makerere University-Johns Hopkins University Research Collaboration in Kampala Uganda. Prof. Musoke chairs the Ministry of Health PMTCT and the paediatric antiretroviral treatment technical subcommittees.

Prof. Musoke has dedicated the past 28 years to teaching at the Makerere Medical School, treating sick children at the Mulago National Referral Hospital, and conducting research at MU-JHU Care Ltd. She has supervised and mentored numerous medical students, postgraduate students including PhD candidates, and junior faculty. At MUJHU, she has mentored and inspired multiple junior investigators, enabling them to become independent investigators. Prof. Musoke is dedicated and committed to excellence in clinical care, training and research.
She is currently the international vice chair of the US, National Institutes of Health (NIH), Division of AIDS, IMPAACT network. Prof. Musoke has published over 150 articles in peer-reviewed journals, presented research findings at national and international conferences, and contributed to the prevention and management of HIV globally. Prof. Musoke is a technical advisor for WHO and other international health organizations.
Since 1995, she has conducted multiple perinatal HIV prevention clinical trials addressing important challenges like the benefit of single dose nevirapine (NVP) to the mother at the onset of labor and her infant at birth to reduce mother-to-child HIV transmission (MTCT) (HIVNET012), infant nevirapine dosing for prevention of breast milk HIV transmission (HPTN046), and the benefit of triple antiretroviral therapy during pregnancy and breastfeeding in further reducing MTCT (PROMISE).

You may like
-
MakSPH Job Opportunity: 30 Research Assistants
-
From Store to Patient: Keeping Uganda’s Medicines Within Reach as Funding Shifts
-
The Road from Climate Promises to Care in Uganda
-
Mayuge Study Finds NCD Risks Emerging in Adolescence, and Shows Early Action Can Help
-
Dr. Alice Nabatanzi Wins Charles Wambebe Innovation Award, Named Best Oral Presenter at APSS 2026 South Africa
-
Makerere Strengthens Doctoral Training Through BURST-Excel Research Network
Makerere University School of Public Health (MakSPH), in collaboration with Charité – Universitätsmedizin Berlin, with funding from Gavi, the Vaccine Alliance, is conducting a study titled: “Vaccination coverage, barriers and the role of the private sector in coffee-farming communities in Uganda: a mixed-methods evaluation of routine, HPV and malaria (R21) immunisation.”
The study team seeks to recruit 30 responsible, qualified, and competent individuals who can work with minimum supervision to join the team as Research Assistants (RAs) for the baseline data collection exercise across 18 study districts.
To Apply, please follow the link: https://sph.mak.ac.ug/careers/?view_job=21676
Health
From Store to Patient: Keeping Uganda’s Medicines Within Reach as Funding Shifts
Published
2 days agoon
November 18, 2026
Uganda’s push for a dependable medicines supply is tested daily at the health facility, where patients expect to receive what was prescribed.
Meeting that expectation means keeping supplies in step with changing needs and sustaining services when funding arrangements change. Uganda has increased funding for essential medicines and health supplies through National Medical Stores and is supporting local pharmaceutical production, as outlined in the government’s FY2026/27 budget statement.
The evidence comes from a Makerere University School of Public Health (MakSPH) project, Safeguarding Uganda’s Health Supply Chain Amid the Global Health Funding Transition: Immediate Actions and Strategic Analytics for Resilience. The project responded to the 2025 suspension of USAID-supported distribution, which left medicines in storage, at risk of expiry, while facilities waited for deliveries.
Led by Prof. Rhoda Wanyenze and Assoc. Prof. Suzanne Kiwanuka, the nine-month project brought together MakSPH, the Ministry of Health and Joint Medical Store (JMS), with support from the Gates Foundation. It was launched on 6 November 2025 with the flag-off of emergency medicine distribution, and four days later MakSPH convened stakeholders to refine the research questions and align them with national priorities. The findings were presented on 3 November 2026 at a national dissemination and policy dialogue.

What reaches the patient
Assoc. Prof. Kiwanuka, the project’s co-principal investigator, led the last-mile assessment with Mr. Amuzah Nshabaruhanga, covering 70 public and private not-for-profit facilities across 15 districts. Of 632 patients interviewed, 591 had been prescribed medicines, and 208 of them, more than one in three, missed at least one prescribed medicine at the facility. Antibiotics and medicines for high blood pressure were among those missed. Of 346 patients requiring diagnostic services, 36 missed a required service.
“The ultimate measure of our supply chain performance should not only be whether commodities are available in the stores, but whether patients actually receive the medicines and the diagnostic services they need,” Assoc. Prof. Kiwanuka said.

Patients said they would buy missing medicines privately, making the ability to pay part of access to treatment. Regional referral hospitals recorded the lowest average annual stock-out rate among the facility levels assessed, at 11.2%, yet 53.5% of their surveyed patients who were prescribed medicines missed at least one. The stock-out rate tracked selected commodities during 2025; patient interviews captured prescription fulfilment during a visit.
Matching supplies with need
Part of the explanation lies in a mismatch between what facilities hold and what they need. A review of 2025 records for 29 tracer commodities found an overall stock-out rate of 15 per cent, measured as the share of days commodities were unavailable. On assessment day, only 13.2% of commodity stocks were at the recommended level: 17.4 per cent were unavailable, 31.7% understocked, and 37.8 per cent overstocked.
The assessment recorded 2,791 redistribution transactions in 2025. Health Centre IIIs and regional referral hospitals were net providers; Health Centre IVs and general hospitals were net recipients. Transfers required staff to locate stock, secure approvals, and arrange transport, often without a dedicated budget. They addressed imbalances linked to mismatched supply kits, restricted order adjustments, delivery delays, and changing demand, highlighting the need for better forecasting and allocation.
Financing dependable delivery

Getting medicines to the facilities that need them also requires reliable delivery funding. Ms. Brenda Nakimuli and Mr. Perez Ochanda’s financing analysis found that the gap between money committed and the estimated cost of essential medicines and health supplies narrowed from 21.7% in FY2022/23 to 1.8% in FY2025/26.
That improvement did not mean every facility had enough funding to order the medicines it needed. These allocations remained UGX99.3 billion below estimated need, while reproductive-health and nutrition supplies also faced shortfalls. Money committed, moreover, is not necessarily money released or spent. Funding for storage, delivery, stock reporting, supervision and staff was spread across budgets, though these costs continue after medicines are bought.
Dr. Catherine Birabwa and Dr. Beatrice Namirembe examined local pharmaceutical manufacturing as part of their assessment of selected supply-chain interventions. Manufacturers and other stakeholders described high operating costs, lengthy product clearance, reliance on foreign expertise, limited technology transfer, and competition from cheaper imports. Local production serves patients only if affordable, quality-assured medicines are procured and delivered where they are needed.
Making information useful
Funding alone does not keep shelves stocked; the system also needs reliable information. Ms. Purity Mukisa of JMS described how the emergency response combined distribution with ordering support, technical supervision, retrieval of expired commodities, and facility mapping. It reached 1,072 facilities and enabled distribution of residual commodities worth approximately US$4.2 million.

“If orders are not coming in, then people cannot have the items that they need. And also we will have expiries because we don’t even know whether the items are being utilised,” Ms. Mukisa said.
Stock reviews also flag products nearing expiry or supplies that could be moved elsewhere. Dr. Birabwa and Dr. Namirembe also examined digital systems, medicines governance and supportive supervision. Health workers described easier ordering, tracking and reporting, but disconnected platforms, inadequate training, unreliable connectivity and delayed technical support limited those gains.
Still, the last-mile assessment by Assoc. Prof. Kiwanuka and Mr. Nshabaruhanga identified difficulties in the electronic medical record system, including automatic stock deduction, batch and expiry management, reporting and communication with other systems. Inaccurate electronic balances can distort later orders. In some facilities, paper requisition tools were withdrawn before electronic processes were fully operational.

Joint Medical Store identified 423 facilities in its network without computers. At one Kampala facility, the team found that the staff member responsible for submitting orders relied on their daughter’s help. Orders did not come through when the daughter was away.
The interventions assessment linked functioning Medicines and Therapeutics Committees and supportive supervision with better ordering, stock management, and accountability. The committees guide medicine selection, prescribing, and monitoring; the Supervision, Performance Assessment and Recognition Strategy (SPARS) provides mentorship and assessment. Funding gaps, staff turnover, and transport constraints weakened both. Donor withdrawal disrupted SPARS, while fragmented implementation weakened the link between digital self-assessment and targeted supervision.
Sustaining the improvements
Each strand of research identifies specific priorities for action. The fiscal-space analysis proposes protecting funding for a minimum package covering distribution, storage, supervision, and stock reporting. The last-mile assessment calls for allocating supplies using consumption data and providing dependable funding for redistribution. The interventions assessment recommends linking medicines committees, digital self-assessment, and supportive supervision so that identified gaps lead to corrective action.
Dr. Charles Olaro, Director General of Health Services, said the research findings had already been presented to the Ministry’s top management. He called for follow-up to identify which recommendations could be put into practice to improve the health supply system.

Prof. Rhoda Wanyenze, MakSPH’s Dean and the project’s principal investigator, thanked the Ministry of Health and Joint Medical Store for a partnership she described as excellent. She called for continued collaboration to improve access to medicines and connect the School’s training with the practical demands of delivering essential services.
“As researchers and academics, we need to remain involved in building a resilient and sustainable system. We have a responsibility to nurture the next generation of health workers. The people who will sustain these systems go through our hands. Working together helps us better appreciate the real-world challenges we expose our students to, so that we can send out a better workforce to support the Ministry of Health and other actors in health,” she said.
The project began with medicines awaiting delivery. Its longer-term value will depend on whether institutions assign responsibility and sustain funding for the work that keeps facilities supplied. For patients, progress becomes tangible when prescribed medicines can be dispensed and required tests performed, without another journey or an additional purchase elsewhere to complete their care.
This week, world leaders, negotiators and researchers are gathered in Antalya, Türkiye, for COP31, the United Nations climate conference, seeking to turn years of climate commitments into action countries can finance and implement. Among them is Dr. John Bosco Isunju, a climate and health researcher at Makerere University School of Public Health, named among TIME’s 100 most influential climate leaders in 2024.
Dr. Isunju led the School’s technical support to the Ministry of Health for Uganda’s 2023 Climate Change Health Vulnerability and Adaptation Assessment (VAA) and the subsequent development of the Health National Adaptation Plan (H-NAP) 2025–2030. The assessment covered 716 health facilities across 43 districts, documenting vulnerabilities that helped shape the country’s priorities for protecting healthcare from climate hazards.

That experience speaks directly to the task before the 9–20 November summit. With “Dynamic and Resilient Health Systems” among the COP31 Presidency’s Action Agenda priorities, the conference is seeking practical solutions and financing to keep services functioning through climate shocks. Adaptation, the practical changes needed to cope with a changing climate, must ultimately reach the facilities where people seek care.
Protecting facilities from floods and drought also safeguards the public investment behind them, giving Uganda’s adaptation effort an economic significance alongside its importance to patients. In a 27 October 2026 statement ahead of COP31, UN Climate Change Executive Secretary Simon Stiell placed climate action within that wider calculation of public benefit.
“More governments are taking climate action right across their economies, to bank the vast benefits of clean energy and climate resilience,” he said. “Almost every major economy, and many medium-sized and smaller economies, now see climate action as a central driver of economic growth, jobs, and affordable and secure energy.”

On 21 October, nearly three weeks before the Antalya talks, the H-NAP was before Ugandan parliamentarians in Kampala. Convened by the Ministry of Health and Parliamentary Forum on Climate Change Uganda, with support from Regenerate Africa and the Clinton Health Access Initiative, the engagement examined the plan and Parliament’s role in securing funding, scrutinising implementation and ensuring accountability.
Presenting the VAA, Dr. Isunju explained that the team examined the hazards facing each area, the extent of exposure and the weaknesses that made services vulnerable. They also considered the communities the facilities served. A flood could turn an already difficult journey to treatment into one that patients and staff could no longer make, as seen in many parts of Uganda, including Kasese.
“Either health workers will not work, or communities will not be able to access care, or outreaches will not be possible because roads are cut off,” he told legislators.

Uganda’s H-NAP grew out of commitments made at COP26 in Glasgow in 2021 to assess health vulnerabilities and develop an adaptation response. The Ministry of Health commissioned the School to undertake the VAA in 2023, with Rockefeller Foundation funding supporting both the assessment and the plan’s development. Developed through stakeholder consultation, with WHO technical support and contributions from other partners, the plan was launched on 22 August 2024.
What the assessment found
The VAA found that drought and floods were disrupting the conditions needed to deliver care. Nearly half of the assessed facilities reported drought exposure, while about two in five reported floods. Among the 284 facilities reporting flood exposure, 141 (about half) said health professionals had been unable to arrive at or leave their workplaces, and 198 (about seven in ten) reported shortages of safe water. Because districts were selected for their history of hazards, these findings describe the assessed facilities and cannot be treated as national estimates.

The H-NAP responds across ten components of the health system, including leadership, workforce training, risk monitoring and sustainable financing. Its proposed actions include revising infrastructure standards and using weather and disease information to warn of health risks earlier. Protecting care requires investment in buildings alongside the people and systems that make them function.
“A significant proportion of healthcare facilities lack water management and safety plans to address contamination risks,” the H-NAP states. “They lack water safety plans and contingency plans for monitoring and reducing contaminants as well as on-site water purification equipment.” Such gaps can leave facilities unable to maintain hygiene, clean equipment and provide treatment safely when water supplies fail or become contaminated.
The H-NAP already includes a budget, giving implementation a basis for resource mobilisation. The UN climate secretariat’s 2026 report on national adaptation plans across sectors identifies the difficulty of turning priorities into fundable projects. It recommends costing specific interventions and securing delivery partners, steps that can help advance Uganda’s health adaptation priorities.
At household level, climate pressures on livelihoods can leave families less able to get care or keep children in school, as community consultations showed.
“Their problems are interconnected. If climate, for example, affects their livelihoods, it directly impacts their health, because that means when they fall sick they can’t get care, and they can’t take their children to school, so things are all interconnected,” Dr. Isunju said.

The Ministry’s Focal Point for Climate Change and Health, Dr. Didacus Namanya, told MPs that resilience, the ability to withstand disruption and keep providing care, must inform how services are built and managed.
“So, our vision in the H-NAP is to have a responsive, adaptive, and resilient health system. Adaptive, we are talking about adaptation. These impacts will not stop; they will continue coming, but we must develop our adaptive capacity. The way we build our health facilities, the way we tackle the disease burden, we must be highly adaptive,” he said.
Dr. Namanya called for district-specific assessments, noting the different conditions in Nakasongola and Bududa, and described an ongoing review of infrastructure design standards. Dr. Isunju reported that guidelines for coordinating climate and health action across institutions were undergoing approval.
A partnership announced in October 2025 by the Rockefeller Foundation and the International Development Research Centre is helping the School and the Clinton Health Access Initiative, working with the Ministry of Health, build an investment case for H-NAP implementation. A separate Ministry of Health and Global Green Growth Institute initiative, begun in June 2026, is advancing climate-resilient water, sanitation and hygiene standards, investment plans for health facilities and the government’s capacity to deliver improvements.

Questions for Antalya
Legislators sought evidence of what implementation had delivered. Terego East MP Hon. Wilfred Babanga Erima asked how much of the plan had been implemented, how many facilities had been audited and refitted for climate resilience, and how funding was divided between domestic and donor sources. Hon. Shafiga Wanyenya, Vice Chairperson of Parliament’s Committee on Climate Change, proposed joint follow-up with the health committee and regular progress reviews.
“Our role is to ask the difficult questions and also identify implementation gaps, to advocate for the vulnerable communities and ensure that the national commitments translate into tangible improvements in the lives of our people,” Hon. Wanyenya said.

Those questions belong in Antalya too. The Yearbook of Global Climate Action 2026 identifies gaps in global data for assessing whether health systems are becoming more resilient, underlining the importance of tracking what adaptation efforts deliver for health.
The COP31 health programme links implementation of the Belém Health Action Plan with a financing framework intended to help turn health priorities into investable projects. Launched on 9 November, the Antalya Initiative for Health Resilience provides a platform for countries to share practical experience. The COP28 adaptation framework sets targets for climate-resilient health services by 2030 and progressively beyond, alongside national adaptation planning by 2030 and multi-hazard early-warning systems by 2027.
The H-NAP gives Uganda a practical agenda for that next stage. It calls for climate and health priorities to enter government budgets and for proposals capable of attracting finance. It also identifies academic partnerships as a route to research and capacity-building funds. Annual reviews would then assess progress and guide subsequent work.
As negotiations continue in Antalya, the next test is whether decisions there, and action at home, help keep care available, on the road to a health facility, and at the water point on which safe treatment depends.
Trending
-
General1 week agoNOTICE: Online Applications for Government Sponsorship for Programmes Offered at Public Universities & Other Tertiary Institutions 2027/2028 AY
-
Agriculture & Environment1 week agoZambia readies to host the 22nd RUFORUM AGM in the Capital Lusaka
-
General1 week agoMakerere-Rotary Launch Student Food for Peace Initiative
-
Research1 week agoYour Research, Your Identity, Your Impact. Makerere Empowers Graduate Students to Go Global Through ORCID
-
General1 week agoRENU Communications Department Graduate Trainee Program: Two (2) Vacancies